Vildan GÖRGÜLÜ, Orhan Cem AKTEPE, Birol ŞAFAK

Investigation of antiphospholipid antibody syndrome markers in the etiology of recurrent miscarriage

This study aimed to determine the markers of antiphospholipid antibody syndrome (APS), which has an important place in the etiology of recurrent miscarriage, and to provide guidance for the treatment of the related disorders. This prospective observational study was performed on 120 female patients admitted to the Obstetrics and Gynecology outpatient clinics due to recurrent pregnancy loss. Blood samples were analyzed using the Enzyme-Linked Immunosorbent Assay (ELISA) technique to find out the levels of APS-associated anticardiolipin (ACA), anti-beta2-glycoprotein I (aβ2GPI), anti-annexin V (aANXV), anti-prothrombin (aPT), and antiphosphatidylserine (aPS) antibodies. A statistically significant difference was found between increased age groups and the number of miscarriages (p=0.03, p

PDF

___

1. Schreiber K, Hunt BJ. Managing antiphospholipid syndrome in pregnancy. Thromb Res. 2019;181:41-6.

2. Jinfeng Xu, Daijuan Chen, Xia Duan, et al. The Association Between Antiphospholipid Antibodies and Late Fetal Loss: A Systematic Review and Meta-Analysis. Acta Obstet Gynecol Scand. 2019;98:1523-33.

3. Prine LW, MacNaughton H. Office management of early pregnancy loss. Am Fam Physician. 2011;84:75-82.

4. Grimstad F, Krieg S. Immunogenetic contributions to recurrent pregnancy loss. Assist Reprod Genet. 2016;33:833-47.

5. Wackenheim C, Hoffman P, Dumestre-Pérard C et al. [Prevalence and characteristics of serum autoantibodies in patients followed for infertility at Grenoble University Hospital]. Presse Med. 2019;48:307-15.

6. Zhu H, Wang M, Dong Y et al. Detection of non-criteria autoantibodies in women without apparent causes for pregnancy loss. Clin Lab Anal. 2019;33:e22994.

7. Krivonos MI, Kh Khizroeva J, Zainulina MS et al. The role of lymphocytic cells in infertility and reproductive failures in women with antiphospholipid antibodies. J Matern Fetal Neonatal Med. 2020;25:1-7.

8. Litvinova E, Darnige L, Kirilovsky A et al. Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria. Front Immunol. 2018;14:2971.

9. Rai RS. Antiphospholipid syndrome and recurrent miscarriage. J Postgrad Med. 2002;48:3-4.

10. Franklin RD, Kutteh WH. Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population. Hum Reprod. 2002;17:2981-5.

11. Van den Boogaard E, Cohn DM, Korevaar JC et al. Number and sequence of preceding miscarriages and maternal age for the prediction of antiphospholipid syndrome in women with recurrent miscarriage. Fertil Steril. 2013;99:188-92.

12. Gris JC, Bouvier S, Nouvellon E et al. Antiphospholid antibodies and the risk of pregnancy complications. Thromb Res. 2017;151:34-7.

13. Nielsen HS, Christiansen OB. Prognostic impact of anticardiolipin antibodies in women with recurrent miscarriage negative for the lupus anticoagulant. Hum Reprod. 2005;20:1720-8.

14. Kelchtermans H, Pelkmans L, de Laat B et al. IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis. J Thromb Haemost. 2016;14:1530-48.

15. Meijide H, Sciascia S, Sanna G et al. The clinical relevance of IgA anticardiolipin and IgA anti-β2 glycoprotein I antiphospholipid antibodies: a systematic review. Autoimmun Rev. Autoimmun Rev. 2013;12:421-5.

16. Danisik H, Bogdanova N, Markoff A. Micromolar Zinc in Annexin A5 Anticoagulation as a Potential Remedy for RPRGL3-Associated Recurrent Pregnancy Loss. Reprod Sci. 2019;26:348-56.

17. Demetriou C, Abu-Amero S, White S, Peskett E et al. Investigation of the Annexin A5 M2 haplotype in 500 white European couples who have experienced recurrent spontaneous abortion. Reprod Biomed Online. 2015;31:681-8.

18. Rand J, Eerden PV, Wu XX et al. Defective annexin A5 crystallization: a mechanism for pregnancy losses in the antiphospholipid syndrome. Thromb Res. 2005;115:77-81.

19. Bizzaro N, Antico A, Musso M et al. A prospective study of 1038 pregnancies on the predictive value of anti-annexin V antibodies for fetal loss. Ann N Y Acad Sci. 2005;1050:348-56.

20. Alijotas-Reig J, Ferrer-Oliveras R, Rodrigo-Anoro MJ et al. Anti-beta (2)-glycoprotein-I and anti-phosphatidylserine antibodies in women with spontaneous pregnancy loss. Fertil Steril. 2010;93:2330-6.

21. Velayuthaprabhu S, Archunan G. Evaluation of anticardiolipin antibodies and antiphosphatidylserine antibodies in women with recurrent abortion. Indian J Med Sci 2005;59:347-52.

22. Sabatini L, Torricelli M, Scaccia V, et al. Increased plasma concentrations of antiprothrombin antibodies in women with recurrent spontaneous abortions. Clin Chem. 2007;53:228-32.

23. Kdous M, Hachicha R, Lombroso R et al. Antiphospholipid antibodies and pregnancy. Tunis Med. 2005;83:1-5.

24. Singh A, Nangia A, Sharma S et al. A Study of Anti Beta-2 Glycoprotein I and Anti-Prothrombin Antibodies in Patients with Unexplained Recurrent Pregnancy Losses. Indian J Hematol Blood Transfus. 2016;32:198–201.